Amjevita Is the FDA-Approved Biosimilar to Humira

Amjevita Is the FDA-Approved Biosimilar to Humira Amjevita is the third biosimilar approved for rheumatoid arthritis and other inflammatory types of arthritis. There have been some concerns expressed regarding biosimilars. READ NOW  READ THESE NEXT What Exactly Are Biosimilars? MORE Inflectra Is the Biosimilar to Remicade MORE Erelzi Is the Biosimilar to Enbrel MORE AN ABOUT.COM BRAND You are receiving this newsletter because you subscribed to the Real Life with Arthritis newsletter. If you wish to unsubscribe, please click here 1500 Broadway, 6th Floor, New York, NY, 10036 © 2017 Verywell.com - All rights reserved. Privacy Policy.